GAVAZZONI, Mara
 Distribuzione geografica
Continente #
NA - Nord America 1.338
EU - Europa 910
AS - Asia 345
OC - Oceania 5
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.602
Nazione #
US - Stati Uniti d'America 1.334
CN - Cina 259
UA - Ucraina 241
IT - Italia 196
PL - Polonia 138
FI - Finlandia 90
DE - Germania 85
GB - Regno Unito 50
HK - Hong Kong 49
FR - Francia 43
IE - Irlanda 35
IN - India 22
SE - Svezia 10
GR - Grecia 8
AU - Australia 5
BE - Belgio 5
CA - Canada 4
TR - Turchia 4
VN - Vietnam 4
RO - Romania 3
AL - Albania 2
CL - Cile 2
JP - Giappone 2
CH - Svizzera 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
SG - Singapore 1
Totale 2.602
Città #
Jacksonville 159
Fairfield 150
Warsaw 138
Woodbridge 115
Ashburn 103
Chandler 87
Ann Arbor 79
New York 74
Helsinki 71
Houston 70
Princeton 70
Beijing 68
Cambridge 59
Seattle 52
Wilmington 52
Hong Kong 48
Nanjing 42
Dublin 35
Lancaster 29
Brescia 28
Shenyang 20
Des Moines 19
Jinan 18
Nanchang 16
Milan 15
Hebei 13
Pune 12
San Diego 11
Shanghai 11
Tianjin 11
Changsha 10
Hangzhou 8
Jiaxing 8
San Francisco 6
Zhengzhou 6
Brussels 5
Haikou 5
Kunming 5
Orange 5
Dong Ket 4
Gunzenhausen 3
Lanzhou 3
Los Angeles 3
Melbourne 3
Redwood City 3
Rome 3
San Nicola 3
Toronto 3
Vergiate 3
Verona 3
Acton 2
Boardman 2
Brindisi 2
Canberra 2
Cazzago San Martino 2
Easton 2
Elbasan 2
Fuzhou 2
Guangzhou 2
Hanover 2
Hyderabad 2
London 2
Ningbo 2
Norwalk 2
Piemonte 2
Prescot 2
Sant'anastasia 2
Sant'angelo Lodigiano 2
Taizhou 2
Tokyo 2
Amman 1
Armeno 1
Bari 1
Belpasso 1
Benevento 1
Berbenno Di Valtellina 1
Bielefeld 1
Borca 1
Capoterra 1
Central 1
Changchun 1
Chatsworth 1
Chicago 1
Frankfurt am Main 1
Gateshead 1
Genova 1
Hunedoara 1
Jinhua 1
Kiev 1
Kuwait City 1
Moldova Noua 1
North York 1
Palermo 1
Pavia 1
Phoenix 1
Redmond 1
Riga 1
Rockville 1
Salò 1
San Jose 1
Totale 1.837
Nome #
Spasmogenic Effects of the Proteasome Inhibitor Carfilzomib on Coronary Resistance, Vascular Tone and Reactivity 261
Efficacy of a combination of natural lipid-lowering and antioxidant agents in hypercholesterolaemic patients 116
Effects of Rosuvastatin vs. Atorvastatin at high doses acutely after STEMI: endothelial dysfunction and inflammatory biomarkers evaluation 116
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 110
Cardiovascular toxicity of carfilzomib on vascular tone , vascular reactivity and endothelial function. 110
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 108
Mechanism of cardiovascular toxicity by proteasome inhibitors: new paradigm derived from clinical and pre-clinical evidence 107
High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction 100
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects 81
Diversa efficacia del trattamento pazienti con sindrome vasovagale e risposta cardioinibitoria con asistolia all'head up tilt test 78
[New pharmacological approaches to ischemic heart disease] 78
Heart failure with preserved ejection fraction: is the role of arterial stiffness established? 78
Prognostic Evaluation Of The Ascending Aorta's Elastic Properties In Patients With Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Long-Term Follow-Up Study. 78
Heart Failure With Preserved Ejection Fraction: Is The Role Of Arterial Stiffness Established?. 72
Tossicità cardiovascolare di Carfilzomib : tono vascolare, reattività vascolare e funzione endoteliale 71
Valore diagnostico del Tilt Test e terapia della sincope riflessa cardioinibitoria 71
Tavi, Arterial Stiffness And Ventricular-Arterial Coupling 70
Gli agenti responsabili del danno miocardico 67
Regressione della placca aterosclerotica e rimodellamento nelle arterie carotidi e femorali durante terapia con statine in prevenzione primaria: risultati ultrasonografici 66
Single Centre pilot study on mechanism of vascular effects of carfilzomib in patients with multiple myeloma; preliminary results on endothelial dysfunction and vascular stiffness. 66
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: A systematic review 62
Effects Of Two Different Combinations Of Nutraceutical Agents In Lipid Lowering And Endothelial Protection. 61
Una rara causa di shock cardiogeno in una giovane donna. 61
Efficacia della terapia con atorvastatina ad alto dosaggio sulla protezione della funzione endoteliale e riduzione dei biomarkers infiammatori nei pazienti con STEMI 60
Embolia polmonare e sindromi coronariche acute: l'importanza di decisioni diagnostico-terapeutiche in urgenza e la consapevolezza di incidere sulla vita di due soggetti 59
Effects of two different combinations of nutraceutical agents in lipid lowering and endothelial protection 59
La sincope: importanza dell'approccio multidisciplinare 57
Decongestion, Arterial Stiffness And Ventricular-Arterial Coupling In Ahf. 52
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 52
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 50
Early Cardiovascular Effects Of Proteasome Inhibitors In Multiple Myeloma: Preliminary Results Of A Single Center Study 44
Endothelial Dysfunction: More Than a New Cardiovascular Risk Factor. 41
The potential antiarrhythmic properties of sacubitril/valsartan: a case report. 39
Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. 33
Prognostic value of right ventricular free wall longitudinal strain in a large cohort of outpatients with left-side heart disease. 32
Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? 10
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry 6
Right ventricle assessment before tricuspid valve interventions 5
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 1
Totale 2.688
Categoria #
all - tutte 10.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201986 0 0 0 0 0 0 0 0 0 0 48 38
2019/2020629 101 17 18 43 26 60 44 70 42 128 34 46
2020/2021455 8 47 10 49 14 66 17 55 43 83 45 18
2021/2022275 11 44 1 11 7 19 3 13 12 35 40 79
2022/2023286 39 7 4 12 31 68 7 36 54 2 16 10
2023/2024335 16 13 38 51 36 107 4 13 53 4 0 0
Totale 2.688